Shen J, Barbera J, Shapiro CM (February 2006). Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Medicine Reviews. 10 (1): 63—76. doi:10.1016/j.smrv.2005.05.004. PMID16376590.
Siniscalchi A, Gallelli L, Russo E, De Sarro G (October 2013). A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. European Journal of Pharmacology. 718 (1–3): 10—16. doi:10.1016/j.ejphar.2013.09.013. PMID24051268.
Candy M, Jones L, Williams R, Tookman A, King M (April 2008). Psychostimulants for depression. Cochrane Database Syst Rev (2): CD006722. doi:10.1002/14651858.CD006722.pub2. PMID18425966.
Malhi GS, Byrow Y, Bassett D, Boyce P, Hopwood M, Lyndon W, Mulder R, Porter R, Singh A, Murray G (March 2016). Stimulants for depression: On the up and up?. Aust N Z J Psychiatry. 50 (3): 203—207. doi:10.1177/0004867416634208. PMID26906078. S2CID45341424.
Bahji A, Mesbah-Oskui L (September 2021). Comparative efficacy and safety of stimulant-type medications for depression: A systematic review and network meta-analysis. J Affect Disord. 292: 416—423. doi:10.1016/j.jad.2021.05.119. PMID34144366.
Van Houdenhove B, Pae CU, Luyten P (February 2010). Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?. Expert Opin Pharmacother. 11 (2): 215—223. doi:10.1517/14656560903487744. PMID20088743. S2CID34827174.
Valdizán Usón JR, Idiazábal Alecha MA (June 2008). Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate. Expert Rev Neurother. 8 (6): 917—927. doi:10.1586/14737175.8.6.917. PMID18505357.
Yennurajalingam S, Bruera E (2014). Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids. Cancer J. 20 (5): 319—324. doi:10.1097/PPO.0000000000000069. PMID25299141. S2CID29351114.
Shen J, Barbera J, Shapiro CM (February 2006). Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Medicine Reviews. 10 (1): 63—76. doi:10.1016/j.smrv.2005.05.004. PMID16376590.
Siniscalchi A, Gallelli L, Russo E, De Sarro G (October 2013). A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. European Journal of Pharmacology. 718 (1–3): 10—16. doi:10.1016/j.ejphar.2013.09.013. PMID24051268.
Candy M, Jones L, Williams R, Tookman A, King M (April 2008). Psychostimulants for depression. Cochrane Database Syst Rev (2): CD006722. doi:10.1002/14651858.CD006722.pub2. PMID18425966.
Malhi GS, Byrow Y, Bassett D, Boyce P, Hopwood M, Lyndon W, Mulder R, Porter R, Singh A, Murray G (March 2016). Stimulants for depression: On the up and up?. Aust N Z J Psychiatry. 50 (3): 203—207. doi:10.1177/0004867416634208. PMID26906078. S2CID45341424.
Bahji A, Mesbah-Oskui L (September 2021). Comparative efficacy and safety of stimulant-type medications for depression: A systematic review and network meta-analysis. J Affect Disord. 292: 416—423. doi:10.1016/j.jad.2021.05.119. PMID34144366.
Van Houdenhove B, Pae CU, Luyten P (February 2010). Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?. Expert Opin Pharmacother. 11 (2): 215—223. doi:10.1517/14656560903487744. PMID20088743. S2CID34827174.
Valdizán Usón JR, Idiazábal Alecha MA (June 2008). Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate. Expert Rev Neurother. 8 (6): 917—927. doi:10.1586/14737175.8.6.917. PMID18505357.
Yennurajalingam S, Bruera E (2014). Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids. Cancer J. 20 (5): 319—324. doi:10.1097/PPO.0000000000000069. PMID25299141. S2CID29351114.
Machado, Myrela O.; Kang, Na‐Young Cindy; Tai, Felicia; Sambhi, Raman D. S.; Berk, Michael; Carvalho, Andre F.; Chada, Lourdes P.; Merola, Joseph F.; Piguet, Vincent; Alavi, Afsaneh (September 2021). Measuring fatigue: a meta‐review. International Journal of Dermatology. 60 (9): 1053—1069. doi:10.1111/ijd.15341. PMID33301180. S2CID228087205.
Malhi GS, Byrow Y, Bassett D, Boyce P, Hopwood M, Lyndon W, Mulder R, Porter R, Singh A, Murray G (March 2016). Stimulants for depression: On the up and up?. Aust N Z J Psychiatry. 50 (3): 203—207. doi:10.1177/0004867416634208. PMID26906078. S2CID45341424.
Van Houdenhove B, Pae CU, Luyten P (February 2010). Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?. Expert Opin Pharmacother. 11 (2): 215—223. doi:10.1517/14656560903487744. PMID20088743. S2CID34827174.
Yennurajalingam S, Bruera E (2014). Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids. Cancer J. 20 (5): 319—324. doi:10.1097/PPO.0000000000000069. PMID25299141. S2CID29351114.